Pharmacy News

Labeling will change for two cholesterol-lowering medications

Effective immediately, FDA has changed the labels on two medications used to bring down LDL cholesterol levels: bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet).

FDA finalizes guidance over benzene carcinogen in drugs

In final guidance that takes effect immediately, FDA restricted manufacturers from using benzene in new and existing prescription drugs as well as nonprescription interventions.

FDA approves safety labeling changes for opioids

FDA gave final approval to required safety labeling updates for opioids. The updates, first included in an April 2023 drug safety communication, include the addition of language stating the risk of overdose increases with higher doses for all opioid analgesics and that immediate-release opioids should not be used for an extended period of time unless a patient’s pain is so severe that it cannot be controlled otherwise.

CDC issues advisory on urgent need to increase vaccination rates for flu, COVID, and RSV

CDC alerted health care professionals concerning the important need to get Americans vaccinated against influenza, COVID-19, and respiratory syncytial virus (RSV) during the 2023–2024 cold season.

Cannabis use in pregnancy linked to poor outcomes, says study

Many states have now legalized cannabis, and pregnant parents often turn to the substance to relieve nausea and pain. However, new data reveal a link to negative pregnancy outcomes.